Genetics and Biotechnology

Biotechnology is the use of biological processes for the production of antibiotics, hormones and other medical applications. Biotechnology holds the promise of finding treatments and cures to diseases that have plagued mankind for millennia. In recent years, certain biotech companies have provided investors with a spectacular return on their money.

Today we’re going to take a dive into the technologies for enhancing our bodies, including synthetic organs and the biotech firms investors should watch.
Continue reading
In part two of our biotech special, we’re looking at some of the most important biotech stories from the last few weeks and how you could profit from them.
Continue reading
In part one of our biotech special, we’re looking at some of the most important current biotech stories and how investors could profit from them.
Continue reading
Swiss researchers have learned to transfer nerve impulses wirelessly. This biotech breakthrough could lead to a cure for paralysis and many other illnesses.
Continue reading

Latest Genetics and Biotechnology articles

Investing in neglected diseases

You may not realise this, but over 1.4 billion people have diseases known collectively as neglected tropical diseases (NTDs). That’s roughly one in five of the global population. The world is getting richer, meaning modern medicine is reaching out ever…

View this article

The exploding market of personal healthtech

You’ve probably heard of the Fitbit. You may have heard some other fitness monitoring gadgets. But what you may not realise is that there is a plethora of “quantified self” health monitoring devices and services available – for both hobby…

View this article

Our chat with the man who helped develop CRISPR

Today, it’s your last free go on Frontier Tech Investor’s content – at least for a while. But if you like what you see, you can take out a trial here. Why would you want to give Frontier Tech Investor…

View this article

Copyright © Southbank Investment Research 2017. All rights reserved

Southbank Investment Research. Registered office: 2nd Floor, Crowne House, 56-58 Southwark Street, London, SE1 1UN. Registered in England and Wales with company no. 9539630 and VAT no. GB 629 7287 94.

Privacy & cookie policy | Terms and conditions | Top ↑